Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Bio-Path Holdings, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 22 | 1 | 2 | −19 |
| Shares | 319.1K | 4 | 31.1K | −287.9K (−90.2%) |
| Value | $370.1K | $5 | $5.29K | −$364.8K (−98.6%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Bio-Path Holdings, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 31,127 | $5.29K | 0.00% |
| Jones Financial Companies LLLP | 1 | $0 | 0.00% |
Sold out (21)
Institutions that held Bio-Path Holdings, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Armistice Capital, LLC | 237,561 | $275.6K |
| Apollon Wealth Management, LLC | 14,880 | $17.3K |
| Vanguard Group Inc | 13,502 | $15.7K |
| Geode Capital Management, LLC | 12,448 | $14.4K |
| Two Sigma Securities, LLC | 12,237 | $14.2K |
| National Bank of Canada | 10,000 | $11.6K |
| Cetera Investment Advisers | 10,000 | $11.6K |
| UBS Group AG | 3,166 | $3.67K |
| BlackRock, Inc. | 2,381 | $2.76K |
| Tower Research Capital LLC (TRC) | 2,350 | $2.73K |
| JPMorgan Chase & Co | 217 | $252 |
| SBI Securities Co., Ltd. | 151 | $175 |
| Tradewinds Capital Management, LLC | 50 | $58 |
| Bank of America Corp | 43 | $50 |
| Morgan Stanley | 35 | $41 |
| Group One Trading, L.P. | 21 | $24 |
| EverSource Wealth Advisors, LLC | 10 | $12 |
| Synergy Investment Management, LLC | 5 | $6 |
| Danske Bank A/S | 2 | $2 |
| Wells Fargo & Company | 1 | $1 |
| Allworth Financial LP | 1 | $1 |
Not filed for Q1 2025 yet (1)
Institutions that held Bio-Path Holdings, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Global Retirement Partners, LLC | 4 | $5 |